Skip to main content

Table 7 Association between polymorphisms of DPYD and GSTP1 genes and gastrointestinal toxicity of chemotherapy

From: Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms

Genotype

Mucositis

Vomiting

Diarrhea

Grade 1–2

Grade 3–4

P

Grade 1–2

Grade 3–4

P

Grade 1–2

Grade 3–4

P

DPYD*5A (c.1627A>G)

WT

2

7

Ref.

14

16

Ref.

7

7

Ref.

HET

1

2

0.700

12

5

0.113

4

2

0.052

HOM

1

0

0.107

2

2

0.900

1

0

0.533

HET + HOM

2

2

0.317

14

7

0.158

5

2

0.107

DPYD*9A (c.85T>C)

WT

4

9

Ref.

23

19

Ref.

11

8

Ref.

HET

0

0

–

5

4

0.965

1

1

0.830

HOM

0

0

–

0

0

–

0

0

–

HET + HOM

0

0

–

5

4

0.965

1

1

0.830

GSTP1 (c.313A>G)

WT

2

7

Ref.

22

12

Ref.

8

7

Ref.

HET

2

2

0.317

5

10

0.042

4

2

0.577

HOM

0

1

0.598

0

1

0.187

0

0

–

HET + HOM

2

3

0.480

5

11

0.027

4

2

0.577